AI assistant
CEMATRIX Corporation — Interim / Quarterly Report 2021
Nov 10, 2021
45635_rns_2021-11-10_1e861d17-89d4-4cbb-abbb-af16576de577.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
==> picture [180 x 57] intentionally omitted <==
CEMATRIX CORPORATION Condensed Consolidated Financial Statements (in 000’s Canadian dollars) September 30, 2021
CEMATRIX CORPORATION
Management’s Responsibility for Financial Reporting and Notice of No Auditor Review of the Interim Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2021
To the Shareholders:
CEMATRIX CORPORATION
Management has responsibility for preparing the accompanying condensed consolidated financial statements. The condensed consolidated financial statements have been prepared by management in accordance with International Financial Reporting Standards. When alternative methods exist, management has chosen those it deems most appropriate in the circumstances. Financial statements are not precise since they include certain amounts based on estimates and judgement. Management has determined such amounts on a reasonable basis in order to ensure that the condensed consolidated financial statements are presented fairly, in all material respects. Management has developed and maintains appropriate accounting and systems of internal control designed to provide reasonable assurance that reliable and relevant financial information is produced. In addition, programs of proper business conduct and risk management have been implemented to protect the Company's assets and operations. Policies and procedures are designed to give reasonable assurance that transactions are appropriately authorized, assets are safeguarded from loss or misuse and financial records are properly maintained to provide reliable financial information for the preparation of the condensed consolidated financial statements.
The Board of Directors (the "Board”) is responsible for ensuring that management fulfills its responsibilities for financial reporting and is ultimately responsible for reviewing and approving the condensed consolidated financial statements. The Board carries out these responsibilities principally through the Audit Committee (the "Committee”), which includes two independent directors.
The Committee has the responsibility of meeting with management to discuss the internal controls over the financial reporting process, auditing matters and financial reporting issues. The Committee reviews the interim condensed consolidated financial statements and reports its findings to the Board for approval.
The Company’s external auditor, MNP LLP, an independent firm of Chartered Professional Accountants, has not performed a review of these interim condensed consolidated financial statements.
November 10, 2021
Signed “Randy Boomhour” Randy Boomhour, CPA, CMA Chief Financial Officer
- 2 -
CEMATRIX CORPORATION Condensed Consolidated Statements of Financial Position
| As at September 30, 2021 (unaudited) and December 31, 2020 (audited) | As at September 30, 2021 (unaudited) and December 31, 2020 (audited) | As at September 30, 2021 (unaudited) and December 31, 2020 (audited) | As at September 30, 2021 (unaudited) and December 31, 2020 (audited) | |
|---|---|---|---|---|
| (in | 000’s Canadian Dollars) | |||
| 2021 | 2020 | |||
| ASSETS | ||||
| Current Assets | ||||
| Cash and cash equivalents | $ | 20,246 | $ | 2,475 |
| Restricted cash | 286 | 286 | ||
| Trade and other receivables_(note 5)_ | 6,515 | 4,329 | ||
| Inventory_(note 6)_ | 722 | 692 | ||
| Prepaid expenses and deposits | 216 | 324 | ||
| 27,985 | 8,106 | |||
| Non-Current Assets | ||||
| Property and equipment | 12,423 | 13,144 | ||
| Goodwill and intangibles_(note 7)_ | 6,733 | 7,274 | ||
| Convertible debt–non-cash derivative asset_(note 14)_ | 255 | 314 | ||
| 19,411 | 20,732 | |||
| Total Assets | $ | 47,396 | $ | 28,838 |
| LIABILITIES and EQUITY | ||||
| Current Liabilities | ||||
| Bank operating loan_(note 8)_ | $ | - | $ | 129 |
| Trade and other payables_(note 10)_ | 3,833 | 2,433 | ||
| Current portion of long-term debt_(note 11)_ | 881 | 1,059 | ||
| Current portion of lease obligations_(note 12)_ | 585 | 584 | ||
| Current portion of earn-out liability_(note 13)_ | - | 2,128 | ||
| Current portion of convertible debt – host debt_(note 14)_ | - | 3,142 | ||
| Current portion of convertible debt–non-cash derivative liability_(note 14)_ | - | 6,398 | ||
| 5,299 | 15,873 | |||
| Non-Current Liabilities | ||||
| Long-term debt_(note 11)_ | 3,180 | 4,909 | ||
| Lease obligations_(note 12)_ | 1,204 | 1,481 | ||
| Convertible debt – host debt_(note 14)_ | 3,138 | 3,787 | ||
| Deferred tax liability | 1,510 | 2,109 | ||
| 9,032 | 12,286 | |||
| Total Liabilities | 14,331 | 28,159 | ||
| SHAREHOLDERS’ EQUITY | ||||
| Share capital_(note 15)_ | 43,555 | 13,802 | ||
| Convertible debt – equity component_(note 14)_ | 536 | 656 | ||
| Contributed surplus | 5,705 | 2,637 | ||
| Accumulated other comprehensive loss | (489) | (464) | ||
| Deficit | (16,242) | (15,952) | ||
| Total Shareholders’ Equity | 33,065 | 679 | ||
| Total Liabilities and Shareholders’ Equity | $ | 47,396 | $ | 28,838 |
Approved on behalf of the Board
Signed “Jeffrey Kendrick” Director
Signed “Steve Bjornson” Director
The accompanying notes are an integral part of these consolidated financial statements.
- 3 -
CEMATRIX CORPORATION
Condensed Consolidated Statements of Loss and Comprehensive Loss
For the three and nine months ended September 30 (unaudited) (in 000’s Canadian Dollars, except per share and share data)
| Three months ended | Three months ended | September 30 | Nine months ended | Nine months ended | September 30 | |||
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Revenue (note 24) | $ | 7,128 | $ | 10,880 | $ | 15,654 | $ | 22,178 |
| Cost of sales (note 16) | (5,542) | (7,927) | (13,429) | (16,943) | ||||
| Gross margin | 1,586 | 2,953 | 2,225 | 5,235 | ||||
| Operating expenses | ||||||||
| Selling, general and administrative | (1,637) | (1,569) | (4,883) | (4,667) | ||||
| Total operating expenses | (1,637) | (1,569) | (4,883) | (4,667) | ||||
| Operating income (loss) | (51) | 1,384 | (2,658) | 568 | ||||
| Non-cash stock-based compensation_(note 20)_ | (93) | (21) | (183) | (93) | ||||
| Finance costs (note 17) | (173) | (408) | (770) | (1,163) | ||||
| Other income (expenses)(note 18) | 292 | (473) | 741 | (676) | ||||
| Amortization of intangibles_(note 7)_ | (180) | (191) | (537) | (581) | ||||
| Accretion costs_(note 17)_ | (83) | (178) | (266) | (470) | ||||
| Revaluation of earn-out liability_(note 13)_ | - | - | 132 | (111) | ||||
| Non-cash fair value adjustment of derivatives_(note 14)_ | - | 180 | 2,722 | 62 | ||||
| Income (loss) before income taxes | (288) | 293 | (819) | (2,464) | ||||
| Provision for deferred taxes | 180 | (1,699) | 609 | (921) | ||||
| Provision for current taxes | (1) | (1) | (80) | (1) | ||||
| Loss attributable to the common shareholders | (109) | (1,407) | (290) | (3,386) | ||||
| Unrealized foreign exchange gain (loss) on translation | ||||||||
| of foreignsubsidiary | 279 | (235) | (25) | 171 | ||||
| Total comprehensive income (loss) for the period | $ | 170 | $ | (1,642) | $ | (315) | $ | (3,215) |
| Loss per common share (note 19) | ||||||||
| Basic and diluted | $ | (0.001) | $ | (0.022) | $ | (0.003) | $ | (0.055) |
| Weighted average number of common shares(note 19) | ||||||||
| Basic and diluted | 131,843,261 | 63,916,930 | 109,161,100 | 61,785,686 |
The accompanying notes are an integral part of these consolidated financial statements.
- 4 -
CEMATRIX CORPORATION Condensed Consolidated Statements of Changes in Shareholders’ Equity
For the three and nine months ended September 30 (unaudited) (in 000’s Canadian Dollars)
| Accumulated | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | Total | |||||||||||||
| Share | Contributed | Comprehensive | Convertible | Shareholders’ | ||||||||||
| Capital | Surplus | Income (Loss) | Debt | Deficit | Equity | |||||||||
| Balance at December 31, 2020 | $ | 13,802 | $ | 2,637 | $ | (464) | $ | 656 | $ | **(15,952) ** | $ | 679 | ||
| Common shares issued(note 15) | 2,016 | - | - | - | - | 2,016 | ||||||||
| Public offering(note 15) | 15,936 | 4,954 | - | - | - | 20,890 | ||||||||
| Reclassification of contributed | ||||||||||||||
| surplus to share capital(note 15) | 825 | (825) | - | - | - | - | ||||||||
| Non-cash stock-based | ||||||||||||||
| compensation(note 20) | - | 42 | - | - | - | 42 | ||||||||
| Convertible debt conversion | ||||||||||||||
| (note 14 and 15) | 570 | 292 | - | (90) | - | 772 | ||||||||
| Exercise of broker warrants(note | ||||||||||||||
| 14 and 15) | 14 | 9 | - | (23) | - | - | ||||||||
| Net income attributable to | ||||||||||||||
| common shareholders | - | - | - | - | 235 | 235 | ||||||||
| Unrealized foreign exchange loss | ||||||||||||||
| on translation of foreign | ||||||||||||||
| subsidiaries | - | - | (150) | - | - | (150) | ||||||||
| Balance at March 31, 2021 | $ | 33,163 | $ | 7,109 | $ | (614) | $ | **543 ** | $ | **(15,717) ** | $ | 24,484 | ||
| Common shares issued(note 15) | 540 | - | - | - | - | 540 | ||||||||
| Reclassification of contributed | ||||||||||||||
| surplus to share capital(note 15) | 910 | (910) | - | - | - | - | ||||||||
| Non-cash stock-based | ||||||||||||||
| compensation(note 20) | - | 48 | - | - | - | 48 | ||||||||
| Convertible debt conversion | ||||||||||||||
| (note 14 and 15) | 6,697 | 27 | - | (6) | - | 6,718 | ||||||||
| Net loss attributable to common | ||||||||||||||
| shareholders | - | - | - | - | (416) | (416) | ||||||||
| Unrealized foreign exchange loss | ||||||||||||||
| on translation of foreign | ||||||||||||||
| subsidiaries | - | - | (154) | - | - | (154) | ||||||||
| Balance at June 30, 2021 | $ | **41,310 ** | $ | 6,274 | $ | (768) | $ | **537 ** | $ | **(16,133) ** | $ | 31,220 | ||
| Common shares issued(note 15) | 1,576 | - | - | - | - | 1,576 | ||||||||
| Reclassification of contributed | ||||||||||||||
| surplus to share capital(note 15) | 664 | (664) | - | - | - | - | ||||||||
| Non-cash stock-based | ||||||||||||||
| compensation(note 20) | - | 93 | - | - | - | 93 | ||||||||
| Convertible debt conversion | ||||||||||||||
| (note 14 and 15) | 5 | 2 | - | (1) | - | 6 | ||||||||
| Net loss attributable to common | ||||||||||||||
| shareholders | - | - | - | - | (109) | (109) | ||||||||
| Unrealized foreign exchange gain | ||||||||||||||
| on translation of foreign | ||||||||||||||
| subsidiaries | - | - | 279 | - | - | 279 | ||||||||
| Balance at September 30, 2021 | $ | **43,555 ** | $ | 5,705 | $ | (489) | $ | **536 ** | $ | **(16,242) ** | $ | 33,065 |
The accompanying notes are an integral part of these consolidated financial statements.
- 5 -
CEMATRIX CORPORATION Condensed Consolidated Statements of Changes in Shareholders’ Equity
For the three and nine months ended September 30 (unaudited) (in 000’s Canadian Dollars)
| Accumulated | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | Total | ||||||||||||
| Share | Contributed | Comprehensive | Convertible | Shareholders’ | |||||||||
| Capital | Surplus | Income (Loss) | Debt | Deficit | Equity | ||||||||
| Balance at December 31, 2019 | $ | 10,953 | $ | 2,945 | $ | (124) | $ | - | $ | (6,202) | $ | 7,572 | |
| Common shares issued_(note 15)_ | 380 | - | - | - | - | 380 | |||||||
| Reclassification of contributed | |||||||||||||
| surplus to share capital_(note 15)_ | 117 | (117) | - | - | - | - | |||||||
| Non-cash stock-based | |||||||||||||
| compensation_(note 20)_ | - | 43 | - | - | - | 43 | |||||||
| Net loss attributable to common | |||||||||||||
| shareholders | - | - | - | - | (1,348) | (1,348) | |||||||
| Unrealized foreign exchange gain | |||||||||||||
| on translation of foreign subsidiaries | - | - | 814 | - | - | 814 | |||||||
| Balance at March 31, 2020 | $ | 11,450 | $ | 2,871 | $ | 690 | $ | - | $ | (7,550) | $ | 7,461 | |
| Common shares issued_(note 15)_ | 766 | - | - | - | - | 766 | |||||||
| Reclassification of contributed | |||||||||||||
| surplus to share capital (note 15) | 245 | (245) | - | - | - | - | |||||||
| Non-cash stock-based | |||||||||||||
| compensation_(note 20)_ | - | 29 | - | - | - | 29 | |||||||
| Net loss attributable to common | |||||||||||||
| shareholders | - | - | - | - | (631) | (631) | |||||||
| Issuance of convertible debt | - | - | - | 888 | - | 888 | |||||||
| Unrealized foreign exchange loss | |||||||||||||
| on translation of foreign subsidiaries | - | - | (408) | - | - | (408) | |||||||
| Balance at June 30, 2020 | $ | 12,461 | $ | 2,655 | $ | 282 | $ | 888 | $ | (8,181) | $ | 8,105 | |
| Common shares issued_(note 15)_ | 501 | - | - | - | - | 501 | |||||||
| Reclassification of contributed | |||||||||||||
| surplus to share capital_(note 15)_ | 149 | (149) | - | - | - | - | |||||||
| Reclassification of contributed | |||||||||||||
| surplus to deficit_(note 20)_ | - | (21) | - | - | 21 | - | |||||||
| Convertible debt conversion_(notes_ | |||||||||||||
| 14 and 15) | 79 | 40 | - | (15) | - | 104 | |||||||
| Exercise of broker warrants_(note 14_ | |||||||||||||
| and 15) | 19 | 11 | - | (30) | - | - | |||||||
| Non-cash stock-based | |||||||||||||
| compensation_(note 20)_ | - | 21 | - | - | - | 21 | |||||||
| Net income attributable to common | |||||||||||||
| shareholders | - | - | - | - | (1,407) | (1,407) | |||||||
| Unrealized foreign exchange loss | |||||||||||||
| on translation of foreign subsidiaries | - | - | (235) | - | - | (235) | |||||||
| Balance at September 30, 2020 | $ | 13,209 | $ | 2,557 | $ | 47 | $ | 843 | $ | (9,567) | $ | 7,089 |
The accompanying notes are an integral part of these consolidated financial statements.
- 6 -
CEMATRIX CORPORATION Condensed Consolidated Statements of Cash Flows
For the three and nine months ended September 30 (unaudited) (in 000’s Canadian Dollars)
| Three months ended September 30 | Three months ended September 30 | Three months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Cash generated from (used in): | ||||||||
| Operating activities | ||||||||
| Net loss attributable to common shareholders | $ | (109) | $ | (1,407) | $ | (290) | $ | (3,386) |
| Add (deduct) non-cash items | ||||||||
| Provision for deferred taxes | (180) | 1,699 | (609) | 921 | ||||
| Depreciation and amortization | 601 | 688 | 1,873 | 2,004 | ||||
| Finance and accretion costs (note 17) | 256 | 586 | 1,036 | 1,633 | ||||
| Non-cash stock-based compensation_(note 20)_ | 93 | 21 | 183 | 93 | ||||
| Loss on sale of equipment (note 18) | - | (4) | - | (6) | ||||
| Non-cash earnout expense_(note 13)_ | - | 577 | - | 577 | ||||
| Unrealized foreign exchange loss (gain)(note 18) | 44 | (117) | (159) | 130 | ||||
| Fair value adjustment of derivatives_(note 14)_ | - | (180) | (2,722) | (62) | ||||
| Fair value adjustment in earn-out liability_(note 13)_ | - | - | (132) | 111 | ||||
| 705 | 1,863 | (820) | 2,015 | |||||
| Net change in non-cash working capital items(note 21) | (1,463) | (1,209) | (731) | (1,474) | ||||
| Cash generated from (used in) operating activities | (758) | 654 | (1,551) | 541 | ||||
| Investing activities | ||||||||
| Purchase of property and equipment | (305) | (64) | (453) | (119) | ||||
| Proceeds on sale of property and equipment | - | 39 | - | 43 | ||||
| Purchase of intangibles_(note 7)_ | - | - | - | (3) | ||||
| Net cash used in investing activities | (305) | (25) | (453) | (79) | ||||
| Financing activities | ||||||||
| Proceeds from bank operating loan_(note 8)_ | - | 118 | - | 118 | ||||
| Repayment of bank operating loan_(note 8)_ | - | - | (129) | (311) | ||||
| Repayment of secured debenture_(note 11)_ | - | - | (1,000) | - | ||||
| Repayment of long-term debt_(note 11)_ | (439) | (651) | (909) | (651) | ||||
| Repayment of finance lease obligations_(note 12)_ | (156) | (138) | (445) | (383) | ||||
| Repayment of earn-out liability_(note 13)_ | (550) | - | (2,047) | - | ||||
| Proceeds from convertible debt_(note 14)_ | - | - | - | 4,836 | ||||
| Proceeds from public offering, net of costs_(note 15)_ | - | - | 20,890 | - | ||||
| Interest paid | (105) | (297) | (683) | (966) | ||||
| Repayment of US operating loan_(note 9)_ | - | (397) | - | (2,210) | ||||
| Proceeds from US operating loan_(note 9)_ | - | - | - | 336 | ||||
| Proceeds from exercise of options and warrants_(note 15)_ | 1,576 | 501 | 4,132 | 1,646 | ||||
| Cash generated from (used in) financing activities | 326 | (864) | 19,809 | 2,415 | ||||
| Foreign exchange effect on cash | (5) | (15) | (34) | 31 | ||||
| Increase (decrease) in cash | (742) | (250) | 17,771 | 2,908 | ||||
| Cash beginning of period | 21,274 | 4,058 | 2,761 | 900 | ||||
| Cash end of period | 20,532 | 3,808 | 20,532 | 3,808 | ||||
| Cash and cash equivalents | 20,246 | 3,728 | 20,246 | 3,728 | ||||
| Restricted cash | 286 | 80 | 286 | 80 | ||||
| $ | 20,532 | $ | 3,808 | $ | 20,532 | $ | 3,808 |
The accompanying notes are an integral part of these consolidated financial statements.
- 7 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
1. Corporate information
CEMATRIX Corporation (“CEMATRIX” or the “Company”) is a limited company incorporated in the province of Alberta, Canada whose common shares are publicly traded in Canada on the TSX Venture Exchange under the symbol “CVX.V” and in the United States on the OTCBB under the symbol “CTXXF”. The Company is domiciled in Canada with its registered office at 9727 – 40th Street S.E., Calgary, Alberta, Canada.
CEMATRIX is a leading manufacturer and supplier of cellular concrete products with applications in a variety of markets across North America. The Company operates through its subsidiaries CEMATRIX (Canada) Inc., CEMATRIX (USA) Inc., MixOnSite USA, Inc. (“MOS”), Pacific International Grout Company (“PIGCO”), and Canadian Cellular Concrete Services Inc. (“CCCS”).
The condensed consolidated financial statements of the Company for the three and nine months ended September 30, 2021 were authorized for issue in accordance with a resolution of the Board of Directors on November 10, 2021.
2. Basis of preparation
Statement of compliance
These condensed consolidated financial statements for the three and nine months ended September 30, 2021 have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations of the International Reporting Interpretation Committee (“IFRIC”).
Basis of measurement and going concern
These condensed consolidated financial statements were prepared on a going concern basis under the historical cost convention except for share-based payment transactions and certain financial instruments which are measured at fair value. Unless otherwise stated, all amounts presented in these financial statements are stated in thousands of Canadian dollars. The Company has also reclassified certain comparative figures to conform to the financial statement presentation adopted for the current year.
Use of estimates and judgements
The preparation of condensed consolidated financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in note 3.
Functional and presentation currency
These condensed consolidated financial statements are presented in Canadian dollars, which is the Company’s functional currency. The functional currency of CEMATRIX (USA) Inc., MOS and PIGCO is U.S. dollars (“USD”).
- 8 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
3. Significant accounting judgements, estimates and assumptions
The preparation of condensed consolidated financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Judgements, estimates and assumptions are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. However, actual outcomes can differ from these estimates.
The key sources of these uncertainties that have a significant risk of causing material adjustment to the amounts recognized in the condensed consolidated financial statements are described in Note 3 of the audited consolidated financial statements for the year ended December 31, 2020. There have been no changes since that date.
4. Significant accounting policies
The significant accounting policies of the Company are outlined in Note 4 of the audited consolidated financial statements for the year ended December 31, 2020. There have been no changes since that date.
- 9 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
5. Trade and other receivables
Trade and other receivables consist of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Trade receivables | $ | 6,095 | $ | 3,760 |
| Holdbacks | 280 | 397 | ||
| Other receivables | 204 | 237 | ||
| Allowancefordoubtfulaccounts | (64) | (65) | ||
| $ | 6,515 | $ | 4,329 |
Trade receivables and holdbacks are unsecured and non-interest bearing and are generally on 30-day terms subject to standard ten percent construction holdbacks on most of its sales over $100. Holdbacks are generally collectible forty-five days after completion of the work performed by the Company, however, holdbacks can be outstanding much longer, if the holdback release is tied to the completion of the entire project by the general contractor. The Company is normally a subcontractor to the general contractor and only completes a portion of the total work to be completed by the general contractor and accordingly certain holdbacks can be outstanding for up to a year or more.
The aging of the trade receivables were as follows as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| 1-30 days | $ | 4,477 | $ | 1,749 |
| 31-60 days | 601 | 443 | ||
| 61-90 days | 752 | 608 | ||
| Greaterthan90 days | 265 | 960 | ||
| $ | 6,095 | $ | 3,760 |
In determining the recoverable amount of a trade, holdbacks and other receivables, the Company performs a risk analysis considering the type and age of the outstanding receivable and the credit worthiness of the counterparties. The Company considers trade accounts receivable past due if they are greater than 60 days, except for holdbacks that have been invoiced and are part of trade receivables but are not collectible until the completion of the entire project as discussed above.
6. Inventory
Inventory consists of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Raw materials (principally foaming agent) | $ | 722 | $ | 692 |
| Spare parts andmarketingmaterial | - | - | ||
| $ | 722 | $ | 692 |
Inventory expensed as part of cost of sales was $251 and $574 for the three and nine months ended September 30, 2021, respectively ($467 and $974 for the same periods in 2020).
- 10 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
7. Goodwill and intangible assets
Goodwill and intangibles consist of the following components as at September 30, 2021 and December 31, 2020:
| Indefinite lives | Product | Sales | |||
|---|---|---|---|---|---|
| intangible assets | testing costs | backlog | Goodwill | Total | |
| Cost | |||||
| At December 31, 2020 | 465 | 302 | 2,267 | 5,779 | 8,813 |
| Additions | - | - | - | - | - |
| Exchange difference | - | - | 2 | 4 | 6 |
| At September 30, 2021 | 465 | 302 | 2,269 | 5,783 | 8,819 |
| Accumulated amortization | |||||
| At December 31, 2020 | - | - | (1,539) | - | (1,539) |
| Amortization | - | - | (537) | - | (537) |
| Exchange difference | - | - | (10) | - | (10) |
| At September 30, 2021 | - | - | (2,086) | - | (2,086) |
| Net book value | |||||
| At September 30, 2021 | 465 | 302 | 183 | 5,783 | 6,733 |
| Cost | |||||
| At December 31, 2019 | 465 | 299 | 2,313 | 5,895 | 8,972 |
| Additions | - | 3 | - | - | 3 |
| Exchange difference | - | - | (46) | (116) | (162) |
| At December 31,2020 | 465 | 302 | 2,267 | 5,779 | 8,813 |
| Accumulated amortization | |||||
| At December 31, 2019 | - | - | (826) | - | (826) |
| Amortization | - | - | (768) | - | (768) |
| Exchange difference | - | - | 55 | - | 55 |
| At December 31,2020 | - | - | (1,539) | - | (1,539) |
| Net book value | |||||
| At December 31, 2020 | 465 | 302 | 728 | 5,779 | 7,274 |
The intangible assets with indefinite lives include foaming agent technology, process licenses and trademarks. The foaming agent technology relates to the cost of obtaining a foaming agent formula which is used by the Company to produce one of the unique foaming agents which it uses in the production of cellular concrete. This foaming agent formula, which enables the production of cellular concrete which has certain unique properties, cannot be easily duplicated. The process licenses relate to the cost of obtaining a mechanical process patent which the Company believes will enhance the production of its cellular concrete. To date the Company has not had the necessary funds to develop this process. The process is protected by the patent which is registered in the U.S. The trademarks relate to cost of initially registering certain trademarks in both Canada and the U.S. These trademarks are renewed as required for a nominal cost. As a result of an assessment of these facts, Management believes that these items have an indefinite life.
- 11 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
7. Goodwill and intangible assets (continued)
Product testing costs relate to third party testing and verification of certain qualities of the Company’s products. This information is particularly important for the further development of the infrastructure market. The product testing costs are not completed and therefore are not available for use. At the end of each testing program, the specific product testing costs related to the particular program will be amortized over future years based on their estimated useful life.
The sales backlog and goodwill were the result of the acquisition of MOS and PIGCO. The sales backlog acquired by the Company in the MOS acquisition is fully amortized, while the backlog acquired in PIGCO acquisition is being amortized over 27 months on a straight-line basis, which is consistent with the time period the Company expects to complete the aforementioned contracts. Goodwill arises principally from the ability to leverage the larger base of operations, the assembled workforce, future growth and the potential to realize synergies in the form of cost savings.
8. Bank operating loan
CEMATRIX’s wholly owned subsidiary, CEMATRIX (Canada) Inc. has entered into a financing arrangement with the Canadian Western Bank (the “Bank”) which provides a $1,500 demand operating loan (the “Loan”). The Loan bears interest at an amount equal to 2% above the Bank’s prime lending rate, which is currently at 2.45% and is secured by a general security agreement providing a first secured interest on the receivables and inventory of CEMATRIX (Canada) Inc. The Loan is further guaranteed by the Company with the Company granting a general security agreement providing a first secured interest on all present and after acquired property of the Company.
Under the Loan, the Bank will advance up to $1,500 based on 75% of trade receivables less than ninety days outstanding at the end of each month and 50% of inventories (up to a maximum $250). Based on these restrictions the actual Loan availability at September 30, 2021 was $1,473 of which $nil was outstanding ($129 – December 31, 2020).
The Loan contains covenants in regard to consolidated cash flow coverage ratio, consolidated debt to tangible net worth ratio, and consolidated current ratio. Up until December 31, 2020, consolidated cash flow coverage ratio was tested annually, with the remaining covenants being tested on a monthly basis; however, as of the first quarter of 2021, consolidated cash flow coverage ratio is now being tested quarterly. At September 30, 2021, CEMATRIX (Canada) Inc. was in compliance with the consolidated debt to tangible net worth and current ratio covenants; however, it was in breach of cash flow coverage ratio. The bank has provided a general tolerance for this covenant breach until the next covenant measurement date of December 31, 2021.
In December 2020, the Company entered into an agreement with the Bank; whereby the Bank provided a letter of credit up to a maximum amount of $206 to be used as security for a certain project. As a result, the Company was required to place this amount as a pledged bank balance, essentially, restricting the use of this cash amount until the project is completed.
- 12 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
9. US Operating loans
US Operating loans consist of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| US operating loan, beginning of the year | $ | - | $ | 2,186 |
| US operating loans assumed on business acquisitions | - | - | ||
| Proceeds of US operating loan | - | 336 | ||
| Repayment of US operating loans | - | (2,631) | ||
| Effect of unrealized foreign exchange loss (gain) on translation | - | 109 | ||
| US operating loan, end of the period | $ | - | $ | - |
10. Trade and other payables
Trade and other payables consist of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Trade payables | $ | 3,102 | $ | 1,160 |
| Accrued interest | 20 | 97 | ||
| Other accruals | 422 | 542 | ||
| Payroll remittance and goods and services tax | 289 | 634 | ||
| $ | 3,833 | $ | 2,433 |
- 13 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
11. Long-term debt
Long-term debt consists of the following components as at September 30, 2021 and December 31, 2020:
| Maturity | Interest rate | 2021 | 2020 | |||
|---|---|---|---|---|---|---|
| BDC financing | ||||||
| Loan 1 | N/A | Floating | $ | - | $ | 167 |
| Loan 2 | N/A | Floating | - | 291 | ||
| Loan 3 | N/A | Floating | - | 12 | ||
| Loan 4 | August 1, 2026 | Floating | 1,386 | 1,528 | ||
| Loan 5 | December 1, 2025 | Floating | 2,675 | 2,970 | ||
| 4,061 | 4,968 | |||||
| Secured debenture | N/A | Fixed | - | 1,000 | ||
| 4,061 | 5,968 | |||||
| Less current portion | (881) | (1,059) | ||||
| $ | 3,180 | $ | 4,909 |
Reconciliation of Long-term debt
The following table reconciles the changes in cash flows from financing activities for the Company’s long-term debt:
| ebt: | ||||
|---|---|---|---|---|
| 2021 | 2020 | |||
| Long-term debt, beginning of the year | $ | 5,968 | $ | 7,281 |
| Repayment of long-term debt | (1,909) | (1,229) | ||
| 4,059 | 6,052 | |||
| Effect of unrealized foreign exchange (gain) loss on income | 3 | (31) | ||
| Effect of unrealized foreign exchange gain on translation | (1) | (53) | ||
| Long-term debt, end of the period | $ | 4,061 | $ | 5,968 |
Business Development Bank of Canada Financing (“BDC Financing”) :
Loan 1 – In June 2016, the Company’s wholly-owned subsidiary, CEMATRIX (Canada) Inc., entered into an agreement with the BDC for a working capital loan of $500. The loan was fully drawn down in December 2016. The interest, payable monthly, was set at 3.86% above the BDC floating base rate. The loan was fully repaid in the first quarter of 2021.
Loan 2 – In October 2016, the Company’s wholly-owned subsidiary, CEMATRIX (Canada) Inc., entered into an agreement with the BDC for an equipment loan of $500. The loan was fully drawn down in April 2019. The interest, payable monthly, was set at 1.85% above the BDC floating base rate. The loan was fully repaid in the first quarter of 2021.
Loan 3 – In March 2017, the Company’s wholly-owned subsidiary, CEMATRIX (Canada) Inc., entered into an agreement with the BDC for a loan of $100 to fund the first-year costs related to a program offered by the BDC that will assist the Company in establishing its growth strategy. The loan was fully drawn down in March 2017. The interest, payable monthly, was set at 1.00% above the BDC floating base rate. The loan was fully repaid in the first quarter of 2021.
- 14 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
11. Long term debt (continued)
Loan 4 – In May 2018 the Company entered into an agreement with the BDC for a loan of $1,800 USD to fund a portion of the purchase price of the MOS acquisition. The interest, which is currently 6.10% and is payable monthly, is set at 1.60% above the BDC floating USD base rate of 4.50%. The loan is repayable over eight years, with seasonal payments of principal required. Payments of principal of $38 USD were required from September to December 2018. Payments of principal of $38 USD are required from July to December for the years 2019 to 2025 and from July to August 2026. On May 31, 2018, the Canadian dollar equivalent of this loan was $2,333. On September 30, 2021, the Canadian dollar equivalent of this was $1,386. The difference being $947 which is due to principal repayments of $928 and unrealized foreign exchange gain of $19 being recognized in the statement of loss and comprehensive loss.
Loan 5 – In October 2019, the Company’s wholly-owned subsidiary, CEMATRIX (USA) Inc. entered into an agreement with the BDC for a loan of $2,800 USD to fund the purchase price of the PIGCO acquisition. The interest, payable monthly, was initially set at 3.70% above the BDC floating USD base rate. Subsequently, in the first quarter of 2021, the interest rate was renegotiated to 1.60% above the BDC floating USD base rate and therefore, currently at 6.10%. The loan is repayable over six years, with seasonal payments of principal required. A principal repayment of $78 USD is required from July to December from years 2020 to 2025. On October 1, 2019, the Canadian dollar equivalent of this loan was $3,708. On September 30, 2021, the Canadian dollar equivalent of this was $2,675. The difference being $1,033, which is the combination of principal repayments of $907 and unrealized foreign exchange gain of $126 being recognized on the translation of foreign subsidiaries.
Loans 4 and 5 may be prepaid, on each anniversary date, up to 15% of the then outstanding principal amount but if not used the prepayment privilege for that anniversary date ceases. In addition to the annual privilege the Company may prepay all or part of the principal outstanding plus any interest owing up to the time of prepayment plus an indemnity equal to three months interest on the prepaid principal at the floating rate then applicable. The prepayment option is considered to be an embedded derivative with a fair value, which is nominal in nature as at September 30, 2021.
The BDC Financing loans are secured with a general security agreement providing a first security interest in the Company’s current owned equipment and new equipment acquired pursuant to the BDC Financings and a security interest in all present and after acquired personal property of the Company subject only to lender charges on receivables and inventory in support of the Company’s demand operating loan and future charges on specific equipment to a creditor for financing the purchase or lease thereof.
The BDC Financing Loan 4 and Loan 5 have a consolidated fixed charge coverage ratio financial covenant which is tested annually. At December 31, 2020 the Company was not in compliance with this covenant. On the same date, the BDC provided a tolerance for this covenant breach for the period up to and including December 31, 2020.
Secured Debenture:
In February 2014, the Company issued a secured debenture for $1,000 to an unrelated party. The interest, payable monthly was set at 9% per annum. The Company fully repaid the secured debenture during the first quarter of 2021.
- 15 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
12. Lease obligations
Lease obligations consist of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Lease obligations, January 1 | $ | 2,065 | $ | 1,972 |
| Additions | 171 | 632 | ||
| Lease payments (including interest) | (569) | (696) | ||
| Interest expense_(note 17)_ | 124 | 177 | ||
| Foreign exchange | (2) | (20) | ||
| Value of lease obligation, end of year | 1,789 | 2,065 | ||
| Less current portion | (585) | (584) | ||
| Lease obligations, end of the period | $ | 1,204 | $ | 1,481 |
The Company’s lease obligations mainly relate to real property leases that are utilized within their operations. The Company has also entered into leases pertaining to various pieces of operating equipment including cars, trucks, trailers and computer equipment. Leases are entered into and terminated when they meet specific business requirements.
13. Earn-out liability
The earn-out will pay the Vendor 70% of the earnings before interest, income taxes, depreciation and amortization (“EBITDA”) of MOS above $500 USD for the first 12 month period after May 31, 2018 and 65% of the EBITDA above $500 USD for the second and third 12 month periods after May 31, 2018. At a 27% discount rate, the earnout liability, which is denominated in USD is measured at fair value through profit or loss (“FVTPL”) and recalculated at every reporting period based upon management's estimate which considers economic conditions, customer demand for MOS’s services and current borrowing rates available to the Company.
In addition, upon acquisition of PIGCO in October 2019, the Company has agreed to pay an annual earn-out payment to the Vendor for four years following the closing date of the acquisition. The earn-out payment is calculated on the operations of PIGCO annually and pay 65% of the EBITDA above $500 USD to the Vendor, ending September 30, 2023.
- 16 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
13. Earn-out liability (continued)
Earn-out liability consists of the following components as at September 30, 2021 and December 31, 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Balance, January 1 | $ | 2,128 | $ | 1,518 |
| Revaluation in the year | (132) | (80) | ||
| Addition | - | 468 | ||
| Payments | (2,047) | - | ||
| Interest (note 17) | 29 | 27 | ||
| Accretion expense (note 17) | 53 | 265 | ||
| Foreign exchange difference | (31) | (70) | ||
| Value of liability, end of the period | - | 2,128 | ||
| Less current portion | - | (2,128) | ||
| Earn-out liability, non-current | $ | - | $ | - |
In the first quarter of 2021, the company paid out Tranche 1 and 2 associated with the MOS acquisition and Tranche 1 associated with PIGCO acquisition. In the third quarter of 2021, the company paid out the last tranche associated with MOS acquisition. The Tranche 2 period in relation with the PIGCO acquisition was completed in the third quarter of 2021 and the Company the EBITDA in PIGCO did not meet the threshold criteria as explained above resulting in no earnout expense for Tranche 2.
- 17 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
14. Convertible debt
(a) In conjunction with the acquisition of MOS on May 31, 2018, a $2,500 USD convertible note was issued to the Vendor. The convertible note bore interest at a rate of 8% per year, payable quarterly, for a period of three years. During the second quarter of 2021, the convertible note was converted into 13,373,684 CEMATRIX common shares.
The convertible note was trifurcated into a conversion feature, prepayment feature and host debt contract. The conversion feature was an embedded derivative as the convertible note violated the fixed for fixed criterion since the convertible note was denominated in a currency other than the Company’s functional currency. The prepayment feature was an embedded derivative as its value was not closely related with the value of the host debt contract. The conversion feature and prepayment feature were measured at FVTPL. Changes in the fair value of the conversion and prepayment feature were recognized in profit or loss. The host debt contract was initially measured at its fair value and subsequently measured at amortized cost over the term to maturity using an effective interest rate of 11.2%.
The fair value of the conversion feature was determined using a Black-Scholes option pricing model. The fair value of the prepayment feature was determined using a modified Black-Scholes option pricing model that incorporated the prepayment penalty and referred to as the Barrier option pricing model.
The following assumptions were used at the time of conversion and at December 31, 2020:
| 2021 | 2020 | |
|---|---|---|
| Estimated fair value per common share | $0.27 | $0.48 |
| Common share price | $0.51 | $0.72 |
| Risk-free interest rate | 0.32% | 0.20% |
| Expected life | - | 0.41 years |
| Expected volatility in stock price | 48.4% | 63.7% |
| Prepayment penalty | - | 5% - 10% |
Convertible note consists of the following components as at September 30, 2021 and December 31, 2020:
| Host Debt | Derivative | ||
|---|---|---|---|
| Contract | Features | Total | |
| At December 31, 2019 | 3,110 | 62 | 3,172 |
| Interest expense | 268 | - | 268 |
| Accretion expense | 98 | - | 98 |
| Interest payment | (268) | - | (268) |
| Unrealized foreign exchange gain | (66) | - | (66) |
| Fair value adjustment loss | - | 6,336 | 6,336 |
| At December 31, 2020 | 3,142 | 6,398 | 9,540 |
| Interest expense (note 17) | 104 | - | 104 |
| Accretion expense (note 17) | 41 | - | 41 |
| Interest payment | (104) | - | (104) |
| Unrealized foreign exchange gain | (165) | - | (165) |
| Fair value adjustment gain | - | (2,754) | (2,754) |
| Conversion to shares | (3,018) | (3,644) | (6,662) |
| At September 30, 2021 | - | - | - |
- 18 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
14. Convertible debt (continued)
- (b) On April 22, 2020, the Company issued unsecured convertible debenture with a total principal amount of $5,720 at a price of $1,000 per debenture. The convertible debenture bears interest at a rate of 8% per year, payable semiannually, till its maturity date of April 22, 2023. At the option of the holder, each debenture is convertible into 2,500 units of the Company at a conversion price of $0.40 per unit, prior to the maturity date. Each unit consists of one common share of the Company and one-half of a share purchase warrant. Each share purchase warrant entitles the holder to purchase one common share of the Company at an exercise price of $0.45 for a period of 36 months, following the date of its issuance. The Company may force the conversion of outstanding debentures, upon 30 days written notice, after a period of 12 months, in the event the Company's common share price exceeds $0.80 per share for the preceding twenty consecutive trading days.
The convertible debentures are compound financial instruments, trifurcated into a forced conversion feature, host debt contract and equity feature. The forced conversion feature is an embedded derivative as its value is not closely related with the value of the host debt contract.
The forced conversion feature is measured at fair value, with changes being recognized in profit or loss. The fair value of the forced conversion feature was determined using a modified Black-Scholes valuation model. The host debt contract was initially measured at its fair value and subsequently measured at amortized cost over the term to maturity, using an effective interest rate of 20.61%.
The equity feature is comprised of a base conversion feature and brokers warrants. The base conversion feature is valued on a residual basis after accounting for the host debt and forced conversion features and represents the 14,300,000 units that are issuable on the conversion of $5,720 convertible debentures. The broker warrants are valued on a fair value basis and represents the 1,100,000 units that were issued on close and included in the transaction costs allocated to the various components. The fair value of the brokers' warrants was also determined using a modified Black-Scholes valuation model with the following assumptions: expected dividend yield of 0%, expected volatility of 65.0%, which is based on historical volatility, risk free interest rate of 0.39% and an expected maturity of 3 years.
Transaction costs of $639 in cash, $220 in additional debentures and 1,100,000 brokers' warrants valued at $300 were incurred on the issuance and have been allocated pro rata to the various components, based on actual allocation of proceeds upon initial recognition. The transaction costs allocated to forced conversion feature was expensed in profit or loss, while the transaction costs allocated to host debt and equity feature were recorded against their respective components. The $220 transaction cost in additional debentures was included with the principal offering for a total consideration of $5,720. The additional debentures have a price of $1,000 per debenture and convertible into units in the same manner as mentioned above for principal offering. The brokers' warrants entitle the holder to acquire one unit of the Company at a conversion price of $0.40 per unit at any time before three years, following the date of this transaction. Each unit consists of one common share and one-half of a share purchase warrant with the same exercise price and expiry term for warrants as mentioned above for principal offering.
At September 30, 2021 and December 31, 2020, the following assumptions were used for forced conversion feature:
| 2021 | 2020 | |
|---|---|---|
| Estimated fair value per common share | $0.028 | $0.026 |
| Common share price | $0.39 | $0.72 |
| Risk-free interest rate | 0.51% | 0.24% |
| Expected life | 1.6 years | 2.3 years |
| Expected volatility in stock price | 67.7% | 65.0% |
- 19 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
14. Convertible debt (continued)
Convertible debenture consists of the following components as at September 30, 2021 and December 31, 2020:
| Host Debt | Forced | Equity | ||
|---|---|---|---|---|
| Contract | Conversion | Feature | Total | |
| At issuance | 5,108 | (126) | 738 | 5,720 |
| Transaction costs allocated | (1,035) | 25 | (149) | (1,159) |
| Interest expense | 309 | - | - | 309 |
| Accretion expense | 251 | - | - | 251 |
| Broker warrants units | - | - | 300 | 300 |
| Transaction costs expensed | - | (25) | - | (25) |
| Deferred tax on equity feature | - | - | (136) | (136) |
| Conversion – shares & warrants (net of tax) | (602) | 19 | (67) | (650) |
| Interest payment | (244) | - | - | (244) |
| Exercise of broker warrants | - | - | (30) | (30) |
| Fair value adjustment gain | - | (207) | - | (207) |
| At December 31, 2020 | 3,787 | (314) | 656 | 4,129 |
| Interest expense (note 17) | 230 | - | - | 230 |
| Accretion expense (note 17) | 172 | - | - | 172 |
| Conversion – shares & warrants (net of tax) | (880) | 27 | (97) | (950) |
| Interest payment | (171) | - | - | (171) |
| Exercise of broker warrants | - | - | (23) | (23) |
| Fair value adjustment loss | - | 32 | - | 32 |
| At September 30, 2021 | 3,138 | (255) | 536 | 3,419 |
Net proceeds of $4,836 were received on the issuance of convertible debenture, which was equal to the gross amount of $5,720 less: 1) cash transaction costs of $639, which were allocated to all the components of the convertible debenture; 2) additional convertible debentures of $220, which were included in the gross amount of the offering, for which no cash was received and considered as part of the transaction costs and; 3) cash transaction costs of $25 which were expensed immediately to profit or loss.
The following table summarizes the changes in convertible debenture and broker warrants units of the Company as at September 30, 2021 and December 31, 2020:
| Number | Number | |||||
|---|---|---|---|---|---|---|
| Of Convertible | Of Broker | |||||
| Debenture Units | Amount | Warrants Units | Amount | |||
| At issuance | 14,300,000 | $ | 5,720 | 1,100,000 | $ | 300 |
| Conversion–shares & warrants | (2,112,500) | (845) | (108,750) | (30) | ||
| At December 31, 2020 | 12,187,500 | 4,875 | 991,250 | 270 | ||
| Conversion–shares & warrants | (3,090,000) | (1,236) | (82,950) | (23) | ||
| At September 30, 2021 | 9,097,500 | 3,639 | 908,300 | 247 |
Each unit can be converted into one common share of the Company and one-half of a share purchase warrant.
- 20 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
15. Share capital
(a) Authorized
Unlimited number of no par value voting common shares Preferred shares – to be issued in series as authorized by the Board of Directors
(b) Issued
The following table summarizes the changes in the issued common shares of the Company for the nine months ended September 30, 2021 and year ended December 31, 2020:
| 2021 | 2021 | 2020 | 2020 | |||
|---|---|---|---|---|---|---|
| Number | Amount | Number | Amount | |||
| of Shares | ($000’s) | of Shares | ($000’s) | |||
| Common shares, beginning of year | 66,776,750 | $ | 13,802 | 59,286,019 | $ | 10,953 |
| Common shares issued(i), (ii), (iii), (iv) | 30,173,204 | 11,404 | 7,490,731 | 2,208 | ||
| Public offering, net of costs(v) | 36,799,984 | 20,890 | - | - | ||
| Reclassification of options | - | 611 | - | 37 | ||
| Reclassification of broker warrants | - | 14 | - | 19 | ||
| Reclassification of warrants – public | ||||||
| offering(v) | - | (4,450) | - | - | ||
| Reclassification of warrants | - | 1,284 | - | 585 | ||
| Common shares, end of the period | 133,749,938 | $ | 43,555 | 66,776,750 | $ | 13,802 |
- (i) In 2020, for gross proceeds of $557 and $1,125 received, the Company issued 1,856,304 and 3,213,177 common shares at a price of $0.30 and $0.35, respectively on the exercise of warrants.
The Company issued 2,112,500 common shares upon the exercise of convertible debenture. The principal amount of $845 was converted and allocated to share capital and contributed surplus (net of transaction costs and tax) based on fair value assigned at the time of issuance. As a result, $443 and $227 was allocated to share capital and contributed surplus, respectively.
For gross proceeds of $84 received, the Company issued 308,750 common shares on the exercise of employee stock options and broker warrants. The exercise price range was between $0.18 and $0.40.
- (ii) In the first quarter of 2021, for gross proceeds of $1,859 received, the Company issued 5,624,432 common shares on the exercise of regular warrants and broker warrants. The exercise price range was between $0.30 and $0.45.
The Company issued 2,865,000 common shares upon the exercise of convertible debentures. The principal amount of $1,146 was converted and allocated to share capital and contributed surplus (net of transaction costs and tax) based on fair value assigned at the time of issuance. As a result, $570 and $292 was allocated to share capital and contributed surplus, respectively.
For gross proceeds of $157 received, the Company issued 666,666 common shares on the exercise of employee stock options. The exercise price range was between $0.20 and $0.26.
- 21 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
15. Share capital (continued)
- (iii) In the second quarter of 2021, for gross proceeds of $307 received, the Company issued 1,022,494 common shares on the exercise of warrants. The exercise price was $0.30.
For gross proceeds of $233 received, the Company issued 1,028,333 common shares on the exercise of employee stock options. The exercise price range was between $0.20 and $0.24.
The Company issued 200,000 common shares upon the exercise of convertible debenture. The principal amount of $80 was converted and allocated to share capital and contributed surplus (net of transaction costs and tax) based on fair value assigned at the time of issuance. As a result, $35 and $27 was allocated to share capital and contributed surplus, respectively.
Additionally, in the second quarter of 2021, the convertible note issued in conjunction with the acquisition of MOS was converted into 13,373,684 common shares, with the convertible note liability balance of $6,662 allocated to share capital upon conversion.
- (iv) In the third quarter of 2021, for gross proceeds of $1,445 received, the Company issued 4,817,595 common shares on the exercise of warrants. The exercise price was $0.30.
For gross proceeds of $131 received, the Company issued 550,000 common shares on the exercise of employee stock options. The exercise price range was between $0.23 and $0.24.
The Company issued 25,000 common shares upon the exercise of convertible debenture. The principal amount of $10 was converted and allocated to share capital and contributed surplus (net of transaction costs and tax) based on fair value assigned at the time of issuance. As a result, $5 and $2 was allocated to share capital and contributed surplus, respectively.
- v) On March 18, 2021, the Company completed a public offering through a short-form prospectus raising $23,000 in gross proceeds. The Offering was for 35,384,600 units at a price of $0.65 per unit of the Company. Additionally, the lead agents were paid a corporate finance fee satisfied by the issuance of 1,415,384 units for a total of 36,799,984 units. Each unit consists of one common share of the Company and one-half of one common share purchase warrant. Each warrant will be exercisable for one common share at a price of $0.81, for a period of 24 months following closing of the Offering. As a result, the total number of warrants that were issued as part of this financing were 18,399,992.
In addition, the Company issued 2,830,768 broker warrants of the Company to the agents equal to 8% of the number of units issued under the Offering. Each broker warrant entitles the holder to acquire one unit of the Company at $0.65 until March 18, 2023. The broker warrants and warrants mentioned above were valued at $4,450 in total, which was reclassified to contributed surplus in the first two quarters of 2021. The fair value per share purchase warrant was determined using the assumptions mentioned in the warrants section below.
The Company paid the agents a cash commission equal to 7% of the gross proceeds of the Offering, amounting to $1,610 and incurred $500 in other transaction costs, resulting in net proceeds of $20,890.
- 22 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
15. Share capital (continued)
(c) Share Purchase Warrants
The following table reflects the issuance of warrants for the nine months ended September 30, 2021 and year ended December 31, 2020, which is recorded in contributed surplus:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Number | Weighted | Number | Weighted | |
| of Warrants | average price | of Warrants | average price | |
| Warrants, beginning of year | 11,545,321 | $0.310 | 15,554,177 | $0.310 |
| Public offering | 18,399,992 | $0.810 | - | - |
| Convertible debenture conversion | 1,545,000 | $0.450 | 1,056,250 | $0.450 |
| Broker warrants conversion | 41,475 | $0.450 | 54,375 | $0.450 |
| Warrants expired | (145,000) | $0.300 | (50,000) | $0.300 |
| Warrants exercised | (11,381,571) | $0.314 | (5,069,481) | $0.332 |
| Warrants, end of the period | 20,005,217 | $0.779 | 11,545,321 | $0.310 |
The fair value per share purchase warrant was determined using the following weighted average assumptions at the time of the issuance using the Black-Scholes option pricing model:
| August 14, | August 23, | March 18, | March 18, | |
|---|---|---|---|---|
| 2019 | 2019 | 2021 | 2021 | |
| Estimated fair value per share purchase | ||||
| warrant | $0.10 | $0.10 | $0.23 | $0.27 |
| Common share price | $0.20 | $0.20 | $0.63 | $0.63 |
| Exercise price | $0.30 | $0.30 | $0.81 | $0.65 |
| Risk-free interest rate | 1.38% | 1.38% | 0.27% | 0.27% |
| Expected life | 2 years | 2 years | 2 years | 2 years |
| Expected volatility in stock price | 111.0% | 112.0% | 81% | 81% |
| Expected annual dividend yield | nil | nil | nil | nil |
The fair value of these warrants was determined at the time of the issuance of convertible debenture using a modified Black-Scholes valuation model with the following assumptions:
| Warrants issued upon | Warrants issued upon | |
|---|---|---|
| conversion of convertible debt | conversion of broker warrants | |
| Estimated fair value per share | ||
| purchase warrant | $0.21 | $0.20 |
| Common share price | $0.40 | $0.40 |
| Exercise price | $0.45 | $0.45 |
| Risk-free interest rate | 0.39% | 0.39% |
| Expected life | 3 years | 3 years |
| Expected volatility in stock price | 65% | 65% |
| Expected annual dividend yield | nil | nil |
- 23 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
15. Share capital (continued)
(d) Broker Warrants Units
The following table reflects the issuance of broker warrants units for the nine months ended September 30, 2021 and year ended December 31, 2020:
| 2021 | 2021 | 2020 | 2020 | |
|---|---|---|---|---|
| Number | Weighted | Number | Weighted | |
| of Units | average price | of Units | average price | |
| Broker warrants, beginning of year | 991,250 | $0.400 | 1,100,000 | $0.400 |
| Public offering | 2,830,768 | $0.650 | - | - |
| Broker warrants exercised | (82,950) | $0.400 | (108,750) | $0.400 |
| Broker warrants, end of the period | 3,739,068 | $0.589 | 991,250 | $0.400 |
16. Cost of sales
Cost of sales consists of the following components for the three and nine months ended September 30, 2021 and 2020:
| Three months ended September 30 | Three months ended September 30 | Three months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | ||
|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | ||||
| Manufacture of cellular concrete | |||||||
| Materials | $ | 3,395 | $ 5,140 | $ | 7,544 | $ | 9,710 |
| Direct labour | 1,133 | 1,625 | 2,990 | 4,042 | |||
| Variable expenses | 618 | 723 | 1,678 | 1,932 | |||
| Fixed overhead | 47 | 38 | 146 | 122 | |||
| Depreciation | 349 | 401 | 1,071 | 1,137 | |||
| $ | 5,542 | $ 7,927 | $ | 13,429 | $ | 16,943 |
- 24 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
17. Finance costs
The finance costs incurred for the three and nine months ended September 30, 2021 and 2020 are as follows:
| Three | months ended | months ended | September 30 | Nine months ended | Nine months ended | September 30 | ||
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Interest | ||||||||
| BDC financings_(note 11)_ | $ | 65 | $ | 114 | $ | 224 | $ | 385 |
| Secured debenture_(note 11)_ | - | 22 | 19 | 75 | ||||
| Convertible debt_(note 14)_ | 75 | 181 | 334 | 404 | ||||
| Lease obligations_(note 12)_ | 39 | 43 | 124 | 134 | ||||
| Bank operating loan_(note 8)_ | - | 6 | - | 18 | ||||
| US operating loan_(note 9)_ | - | 12 | - | 110 | ||||
| Earn-out liability_(note 13)_ | (6) | - | 29 | (1) | ||||
| Other | - | 30 | 40 | 38 | ||||
| $ | 173 | $ | 408 | $ | 770 | $ | 1,163 |
The accretion costs incurred for the three and nine months ended September 30, 2021 and 2020 are as follows:
| Three | months ended | months ended | September 30 | Nine months ended | Nine months ended | September 30 | ||
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Accretion | ||||||||
| Earn-out liability_(note 13)_ | $ | - | $ | 47 | $ | 53 | $ | 217 |
| Convertible debt_(note 14)_ | 83 | 131 | 213 | 253 | ||||
| $ | 83 | $ | 178 | $ | 266 | $ | 470 |
18. Other income (expenses)
Other income (expenses) for the three and nine months ended September 30, 2021 and 2020 consists of the following:
| Three | months ended | months ended | September 30 | Nine | months ended September 30 | months ended September 30 | months ended September 30 | |
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Unrealized foreign exchange gain | ||||||||
| (losses) | $ | (44) | $ | 117 | $ | 159 | $ | (130) |
| Realized foreign exchange losses | 42 | (24) | 61 | (42) | ||||
| Gain (loss) on sale of equipment | - | 4 | - | 6 | ||||
| Government subsidies | 267 | - | 495 | - | ||||
| Equipment rental | 24 | 24 | 71 | 71 | ||||
| Earn-out expense_(note 13)_ | - | (577) | - | (577) | ||||
| Other | 3 | (17) | (45) | (4) | ||||
| $ | 292 | $ | (473) | $ | 741 | $ | (676) |
The Company received wage and rent subsidies of $267 and $495 for the three and nine months ended September 30, 2021, respectively, as part of the various COVID-19 relief programs initiated by the Federal Government.
- 25 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
19. Loss per common share
The number of common shares included in the computation of basic and diluted loss per common share for the three and nine months ended September 30, 2021 and 2020 is as follows:
| Three months ended September 30 | Three months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | |
|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |
| Weighted average common shares | ||||
| outstanding - basic | 131,843,261 | 63,916,930 | 109,161,100 | 61,785,686 |
| Effect of dilutive instruments | - | - | - | - |
| 131,843,261 | 63,916,930 | 109,161,100 | 61,785,686 |
The dilutive securities for the three and nine months ended September 30, 2021 and 2020 have no dilutive effect as the Company incurred losses in these periods.
- 26 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
20. Non-cash stock-based compensation
Stock option grants
The Company has an Omnibus Equity Incentive Plan (“OEI Plan”) for the issue of up to 10% of the issued and outstanding common shares of the Company. Stock options are part of the OEI Plan. All options that are outstanding will expire upon maturity, or earlier, if the optionee ceases to be a director, officer, employee or consultant or there is a merger, amalgamation or change in control of the Company. The purpose of the option grants is to reward and retain directors, management and consultants important to the continued operation and growth of the Company.
The following table summarizes the changes in options for the nine months ended September 30, 2021 and year ended December 31, 2020:
| 2021 | 2021 | 2020 | 2020 | |
|---|---|---|---|---|
| Number of | Weighted | Number of | Weighted | |
| Options | average price | Options | average price | |
| Outstanding, beginning of period | 4,845,000 | $0.266 | 4,820,000 | $0.230 |
| Granted | 1,235,000 | $0.451 | 550,000 | $0.555 |
| Exercised | (2,245,000) | $0.232 | (200,000) | $0.200 |
| Forfeited | (103,334) | $0.394 | (250,000) | $0.200 |
| Expired | (156,666) | $0.238 | (75,000) | $0.353 |
| Outstanding, end of period | 3,575,000 | $0.349 | 4,845,000 | $0.266 |
| Exercisable, end of the period | 1,690,000 | $0.229 | 3,838,334 | $0.232 |
The following table summarizes the stock options to acquire common shares outstanding as at September 30, 2021:
| Weighted average | Weighted average | Weighted average | |||
|---|---|---|---|---|---|
| Range of | Options | Options | remaining life | exercise price – | exercise price – |
| exercise prices | Outstanding | Exercisable | (years) | options outstanding | options exercisable |
| $0.19 - $0.22 | 760,000 | 560,000 | 2.12 | $0.20 | $0.20 |
| $0.23 - $0.39 | 1,080,000 | 1,080,000 | 1.07 | $0.24 | $0.24 |
| $0.40-$0.59 | 1,735,000 | 50,000 | 3.56 | $0.49 | $0.43 |
| $0.19 - $0.59 | 3,575,000 | 1,690,000 | 2.25 | $0.35 | $0.23 |
At the date of grant, the per share fair value of the options granted and other assumptions, using the Black-Scholes option pricing model are as follows:
| 2021 | 2020 | |
|---|---|---|
| Estimated fair value per option | $0.30 - $0.41 | $0.29 - $0.42 |
| Weighted average common share price | $0.45 | $0.56 |
| Risk-free interest rate | 0.24% - 0.47% | 0.21% - 0.26% |
| Expected life | 5 years | 5 years |
| Expected volatility in stock price | 93% - 95% | 95% |
| Expected annual dividend yield | nil | nil |
| Estimated forfeiture rate | nil | nil |
- 27 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
20. Non-cash stock-based compensation (continued)
Restricted share unit grants
The Company has an Omnibus Equity Incentive Plan (“OEI Plan”) for the issue of up to 10% of the issued and outstanding common shares of the Company. Restricted Share Units (“RSU’s”) are part of the OEI Plan. In the second quarter of 2021, the Company issued RSU’s under the OEI plan. Subject to the specific provisions of the RSU plan, eligibility, vesting period, terms of the RSU’s and the number of RSU’s granted are to be determined by the Board of Directors at the time of the grant. The purpose of the RSU grants is to reward and retain directors, management and consultants important to the continued operation and growth of the Company.
The following tables summarizes the changes in Company’s outstanding RSU’s:
| 2021 | 2020 | |
|---|---|---|
| Number of RSU’s | Number of RSU’s | |
| Outstanding, beginning of period | - | - |
| Granted | 210,526 | - |
| Outstanding, end of period | 210,526 | - |
The fair value of each RSU granted was determined by using the company’s share price on the grant date. The estimated fair value of the RSU’s granted is being recognized as an expense over the three years vesting period of the RSU’s.
Non-Cash Stock Based Compensation
Non-cash stock-based compensation for the three and nine months ended September 30, 2021 of $93 and $183, respectively (2020 – $21 and $93, respectively) was recognized in the consolidated statement of loss and comprehensive loss with an offsetting amount charged to contributed surplus. Non-cash stock-based compensation has no current period impact on the Company’s cash position.
21. Change in non-cash working capital
The changes in non-cash working capital items - asset (increases) decreases and liability increases (decreases) - are outlined below for the three and nine months ended September 30, 2021 and 2020:
| Three months ended September 30 | Three months ended September 30 | Three months ended September 30 | Three months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | Nine months ended September 30 | |
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Trade and other receivables | $ | (3,342) | $ | (3,709) | $ | (2,240) | $ | (3,952) |
| Inventory | 19 | 55 | (31) | (264) | ||||
| Prepaid expenses and deposits | 26 | 16 | 105 | 58 | ||||
| Trade and other payables | 1,834 | 2,429 | 1,435 | 2,684 | ||||
| $ | (1,463) | $ | (1,209) | $ | (731) | $ | (1,474) |
- 28 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
22. Financial instruments and risk management
Set out below is a comparison, by category, of the carrying amounts and fair values of all of the Company’s financial instruments that are carried in the consolidated financial statements and how the fair value of financial instruments are measured.
Fair values
Non-derivative financial instruments
The fair values of cash and cash equivalents, restricted cash, trade and other receivables and trade and other payables approximate their carrying values due to the relatively short periods to maturity of these instruments.
The fair value of the BDC Financing loans approximate its carrying value as the debt rate floats with prime and is
representative of market rates offered to the Company.
At the date of issue, the fair value of the debt components of the convertible debt was estimated using the prevailing market interest rates for similar non-convertible instruments. This amount was recorded as a liability on an amortized cost basis using the effective interest method until extinguished upon conversion or at the instrument’s maturity date. The fair value of the equity feature of the convertible debt was determined at issue date by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This conversion option is recognized net of income tax effects as equity and is not subsequently re-measured.
Fair value represents the price at which a financial instrument could be exchanged in an orderly market, in an arm’s length transaction between knowledgeable and willing parties who are under no compulsion to act. The Company classifies the fair value of the financial instruments according to the following hierarchy based on the amount of observable inputs used to value the instrument.
Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1. Prices in level 2 are either directly or indirectly observable as of the reporting date. Level 2 valuations are based on inputs, including quoted forward prices for commodities, time value and volatility factors, which can be substantially observed or corroborated in the marketplace. The embedded derivatives related to the forced conversion, prepayment and conversion features on the convertible debt are measured based on level 2 (note 14).
Level 3 – Valuations in this level are those with inputs for the assets or liabilities that are not based on observable market date. The earn-out liability is measured at level 3 (note 13).
There were no transfers between level 1, 2 and 3 inputs during the year.
- 29 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements
For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
22. Financial instruments and risk management (continued)
Risk management
The Company’s activities are exposed to a variety of financial risks: interest rate risk, credit risk, liquidity risk and foreign exchange risk. The Company’s overall risk management program focuses on the unpredictability of financial and economic markets and seeks to minimize potential adverse effects on the Company’s financial performance. Risk management is carried out by financial management in conjunction with overall Company governance.
(a) Interest Rate Risk
The BDC Financings, which totalled $4,061 at September 30, 2021 are subject to floating market rates. Based on the floating rate debt outstanding, a 1% increase/decrease in interest rates would result in an increase/decrease in net loss attributable to common shareholders of approximately $31.
- (b) Credit Risk
The Company is responsible for reviewing the credit risk for each customer before standard payment and delivery terms and conditions are offered. The Company review consists of external ratings, when available, and in some cases bank and trade references. Management has established a credit policy under which new customers are analyzed for creditworthiness before the Company extends credit. The Company monitors its trade and other receivables aging on an ongoing basis as part of its process in managing its credit risk.
The Company also manages credit risk related to trade and other receivables on a consolidated basis whereby the aggregate exposure to individual customers is reviewed and their credit quality is assessed.
Financial instruments that subject the Company to credit risk consist primarily of cash and cash equivalents, restricted cash and trade receivables. The Company’s cash and cash equivalents is held with large established financial institutions. The Company manages credit risk using credit approval and monitoring practices. Management is not materially concerned about the credit quality and collectability of accounts receivables, as our customers are predominantly large in scale and of high creditworthiness, and the concentration of credit risk is limited as our largest customers change year to year depending on which projects are being completed. At September 30, 2021, the Company had $20,246 of cash and cash equivalents (2020 - $2,475) and $286 in restricted cash (2020 - $286).
- 30 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
22. Financial instruments and risk management (continued)
(c) Liquidity Risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations. Liquidity risk management involves maintaining sufficient cash and cash equivalents and the availability of working capital financing to meet its financial obligations.
The table below summarizes the maturity profile of the Company’s financial liabilities at September 30, 2021 and December 31, 2020 based on contractual undiscounted payments:
| Less than 1 year | Less than 1 year | 1 to 2 years | 2 to 6 years | Total | ||||
|---|---|---|---|---|---|---|---|---|
| As at September 30, 2021 | ||||||||
| Bank operating loan | $ | - | $ | - | $ | - | $ | - |
| Trade and other payables | 3,833 | - | - | 3,833 | ||||
| Long-term debt | 881 | 1,762 | 1,418 | 4,061 | ||||
| Lease obligations | 705 | 1,098 | 196 | 1,999 | ||||
| Earn-out liability | - | - | - | - | ||||
| Convertible debt | - | 3,639 | - | 3,639 | ||||
| $ | 5,419 | $ | 6,499 | $ | 1,614 | $ | 13,532 | |
| As at December 31, 2020 | ||||||||
| Bank operating loan | $ | 129 | $ | - | $ | - | $ | 129 |
| Trade and other payables | 2,433 | - | - | 2,433 | ||||
| Long-term debt | 1,059 | 2,411 | 2,498 | 5,968 | ||||
| Lease obligations | 740 | 1,177 | 477 | 2,394 | ||||
| Earn-out liability | 2,128 | - | - | 2,128 | ||||
| Convertible debt | 3,183 | - | 4,875 | 8,058 | ||||
| $ | 9,672 | $ | 3,588 | $ | 7,850 | $ | 21,110 |
(d) Foreign Exchange Risk
Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. The Company’s exposure relates to balances denominated in USD and the operations of its U.S. subsidiary which are predominantly in USD. The Company does not hedge these items as the timing of related transactions is not certain. However, the management manages and mitigates foreign exchange risk by monitoring exchange rate trends and forecasted economic conditions.
- 31 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
22. Financial instruments and risk management (continued)
As at September 30, 2021 and December 31, 2020 the following balances are denominated in USD:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Cash and cash equivalents | $ | 449 | $ | 924 |
| Trade and other receivables | $ | 2,096 | $ | 2,219 |
| Prepaid expenses and deposits | $ | 56 | $ | 97 |
| Trade and other payables | $ | 1,267 | $ | 997 |
| Long term debt | $ | 3,187 | $ | 3,533 |
| Lease obligations | $ | 886 | $ | 1,024 |
| Earn-out liability | $ | - | $ | 1,671 |
| Convertible debt – host debt and derivative liability | $ | - | $ | 7,493 |
The Company’s primary foreign exchange sensitivity is in relation to movements of the USD against the Canadian dollar. Based on USD balances as at September 30, 2021, a 1% increase/decrease of the USD against the Canadian dollar would result in an increase/decrease in net loss of approximately $33.
23. Capital management
Management defines capital as the Company’s total shareholders’ equity, its debt and finance lease obligations. The Company manages its capital structure and adjusts it in response to changes in economic conditions and the risk characteristics of its underlying assets. The Board of Directors does not establish a quantitative return on capital for management, but rather promotes year over year sustainable profitable growth. In addition, the Board of Directors has established policies to monitor the Company’s performance against its operating and capital budgets and forecasts.
The Company’s current objective when managing capital is to increase the Company’s capital through growth in earnings and to re-invest the earnings generated to facilitate the continued growth in the Company, in order to provide an appropriate rate of return to shareholders.
Management reviews its capital management approach on an ongoing basis. There were no material changes to this approach during the nine months ended September 30, 2021. The Company is subject to externally imposed financial covenants with its bank operating loan and long-term debt loans 4 and 5.
The total capitalization as at September 30, 2021 and December 31, 2020 is outlined below:
| 2021 | 2020 | |||
|---|---|---|---|---|
| Bank operating loan (note 8) | $ | - | $ | 129 |
| Long term debt_(note 11)_ | 4,061 | 5,968 | ||
| Lease obligations_(note 12)_ | 1,789 | 2,065 | ||
| Convertible debt–host debt and derivative liability_(note 14)_ | 3,138 | 13,327 | ||
| Total debt | 8,988 | 21,489 | ||
| Shareholders’equity | 33,065 | 679 | ||
| $ | 42,053 | $ | 22,168 |
- 32 -
CEMATRIX CORPORATION Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (unaudited) (in 000’s Canadian Dollars)
24. Geographical segmented information
The Company has one operating segment and its primary business is the supply and placement of cellular concrete. It currently markets its services in Canada and the U.S. The tables below, present the sales to external customers for the three and nine months ended September 30, 2021 and 2020 and the total non-current assets attributable to the Company’s geographical segments as at September 30, 2021 and December 31, 2020:
| Three | months ended | months ended | September 30 | Nine | months ended September 30 | months ended September 30 | months ended September 30 | |
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2021 | 2020 | |||||
| Sales to external customers | ||||||||
| Canada | $ | 3,965 | $ | 2,048 | $ | 6,546 | $ | 3,902 |
| U.S. | 3,163 | 8,832 | 9,108 | 18,276 | ||||
| $ | 7,128 | $ | 10,880 | $ | 15,654 | $ | 22,178 |
| 2021 | 2020 | |||
|---|---|---|---|---|
| Total non-current assets | ||||
| Canada | $ | 4,033 | $ | 4,280 |
| U.S. | 15,378 | 16,452 | ||
| $ | 19,411 | $ | 20,732 |
- 33 -